Skip to main navigation
Skip to search
Skip to main content
Experts@Minnesota Home
Home
Profiles
Research units
University Assets
Projects and Grants
Research output
Press/Media
Datasets
Activities
Fellowships, Honors, and Prizes
Search by expertise, name or affiliation
Induction of tumor cell apoptosis by TRAIL gene therapy
Thomas S. Griffith
Urology
Research output
:
Chapter in Book/Report/Conference proceeding
›
Chapter
4
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Induction of tumor cell apoptosis by TRAIL gene therapy'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Gene Therapy
100%
Tumor Necrosis Factor-related Apoptosis-inducing Ligand (TRAIL)
100%
Tumor Cell Apoptosis
100%
Soluble TNF
44%
Tumor
22%
Immune System
11%
Induced Apoptosis
11%
Intravenous Injection
11%
Cell Proliferation
11%
Recombinant
11%
Complementary DNA (cDNA)
11%
Pharmacokinetic Profile
11%
Autoimmune Disease
11%
Cell Death
11%
Family Members
11%
Tumor Formation
11%
Adenoviral Vector
11%
Alternative Means
11%
Multiple Injections
11%
Transformed Cells
11%
Fas Ligand
11%
Tumor-free
11%
Functional Change
11%
Immune Privilege
11%
Apoptosis-inducing Activity
11%
Immunological Function
11%
Cellular Activation
11%
Tumoricidal Activity
11%
In Vivo Half-life
11%
Histological Changes
11%
Tumor Necrosis Factor Superfamily
11%
Small Tumor
11%
Activation-induced Cell Death
11%
Tumor Implantation
11%
Healthy Animals
11%
Tumor Evasion
11%
Tumor Necrosis Factor Ligand
11%
Inhibit Tumor
11%
Immunology and Microbiology
TRAIL
100%
Tumor Cell
100%
Tumor Necrosis Factor Related Apoptosis Inducing Ligand
100%
Programmed Cell Death
100%
Tumor Necrosis Factor
22%
Antineoplastic Activity
11%
Autoimmune Disease
11%
Cell Death
11%
Murine
11%
Fas Ligand
11%
Immune Privilege
11%
Adenovirus Vector
11%
Excitement
11%
Transformed Cell Line
11%
Pharmacokinetics
11%
Immune System
11%
Biochemistry, Genetics and Molecular Biology
Gene Therapy
100%
Tumor Necrosis Factor
100%
Programmed Cell Death
100%
Complementary DNA
8%
Cell Excitability
8%
Immunity
8%
Adenovirus Vector
8%
Murine
8%
Antineoplastic Activity
8%
Immune Privilege
8%
Cell Death
8%
Carcinogenesis
8%
Pharmacokinetics
8%
Fas Ligand
8%
Pharmacology, Toxicology and Pharmaceutical Science
Tumor Necrosis Factor Related Apoptosis Inducing Ligand
100%
Neoplasm
100%
Tumor Necrosis Factor
22%
Murine
11%
Receptor
11%
Adenovirus Vector
11%
Carcinogenesis
11%
Complementary DNA
11%
Fas Ligand
11%
Autoimmune Disease
11%
Pharmacokinetics
11%